| Basics |
|
PepGen Inc. Common Stock
|
| IPO Date: |
May 6, 2022 |
| Sector: |
Healthcare |
| Industry: |
Biotech |
| Market Cap: |
$373.99M |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.39 | 4.86%
|
| Avg Daily Range (30 D): |
$0.26 | 5.23%
|
| Avg Daily Range (90 D): |
$0.17 | 5.22%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
.46M |
| Avg Daily Volume (30 D): |
.71M |
| Avg Daily Volume (90 D): |
2.25M |
| Trade Size |
| Avg Trade Size (Sh.): |
128 |
| Avg Trade Size (Sh.) (30 D): |
107 |
| Avg Trade Size (Sh.) (90 D): |
122 |
| Institutional Trades |
| Total Inst.Trades: |
90 |
| Avg Inst. Trade: |
$1.8M |
| Avg Inst. Trade (30 D): |
$.6M |
| Avg Inst. Trade (90 D): |
$1.07M |
| Avg Inst. Trade Volume: |
.25M |
| Avg Inst. Trades (Per Day): |
1 |
| Market Closing Trades |
| Avg Closing Trade: |
$3.14M |
| Avg Closing Trade (30 D): |
$.61M |
| Avg Closing Trade (90 D): |
$3.13M |
| Avg Closing Volume: |
335.64K |
|
|
| Financials |
| |
TTM |
Q3 2025 |
Q2 2025 |
|
Basic EPS
|
$-2.82
|
$-.52
|
$-.7
|
|
Diluted EPS
|
$-2.82
|
$-.52
|
$-.7
|
|
Revenue
|
$ M
|
$ M
|
$ M
|
|
Gross Profit
|
$
|
$
|
$
|
|
Net Income / Loss
|
$ -93.56M
|
$ -18.03M
|
$ -23.09M
|
|
Operating Income / Loss
|
$ -98.25M
|
$ -18.65M
|
$ -23.93M
|
|
Cost of Revenue
|
$
|
$
|
$
|
|
Net Cash Flow
|
$ 100.52M
|
$ 107.7M
|
$ -14.33M
|
|
PE Ratio
|
|
|
|
|
|
|